Cours Tetra Bio Pharma Inc Canadian Securities Exchange
Actions
TBP
CA88166Y1007
Produits pharmaceutiques
CA 2020 | - | CA 2021 | - | Capitalisation | 88,81 M 121 M 79,32 M |
---|---|---|---|---|---|
Résultat net 2020 | -26 M -35,54 M -23,22 M | Résultat net 2021 | -52 M -71,08 M -46,45 M | VE / CA 2020 | - |
Trésorerie nette 2020 | 501 k 684 k 447 k | Trésorerie nette 2021 | 1,77 M 2,43 M 1,58 M | VE / CA 2021 | - |
PER 2020 |
-1,86
x | PER 2021 |
-1,7
x | Employés | - |
Rendement 2020 * |
-
| Rendement 2021 |
-
| Flottant | 99,01% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01/06/16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01/06/16 |
Catherine Auld
BRD | Director/Board Member | - | 28/05/21 |
H. Norton
CHM | Chairman | 63 | 17/09/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+9,94% | 4,99 Md | |
-32,21% | 3,61 Md | |
-1,43% | 3,1 Md | |
-25,09% | 2,64 Md | |
-11,46% | 2,32 Md | |
+36,65% | 1,85 Md | |
+37,15% | 1,43 Md | |
-16,01% | 1,39 Md | |
+40,95% | 1,37 Md |